nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexfenfluramine—Methamphetamine—Nateglinide—type 2 diabetes mellitus	0.216	1	CrCrCtD
Dexfenfluramine—HTR2C—type 2 diabetes mellitus	0.134	0.393	CbGaD
Dexfenfluramine—CYP2E1—type 2 diabetes mellitus	0.107	0.311	CbGaD
Dexfenfluramine—CYP1A2—type 2 diabetes mellitus	0.101	0.296	CbGaD
Dexfenfluramine—HTR2B—Bromocriptine—type 2 diabetes mellitus	0.0385	0.0996	CbGbCtD
Dexfenfluramine—CYP2A6—Rosiglitazone—type 2 diabetes mellitus	0.0321	0.083	CbGbCtD
Dexfenfluramine—HTR2C—Bromocriptine—type 2 diabetes mellitus	0.0251	0.0648	CbGbCtD
Dexfenfluramine—CYP2C19—Gliclazide—type 2 diabetes mellitus	0.0169	0.0438	CbGbCtD
Dexfenfluramine—CYP2C9—Glimepiride—type 2 diabetes mellitus	0.0166	0.0428	CbGbCtD
Dexfenfluramine—CYP2C9—Glipizide—type 2 diabetes mellitus	0.0151	0.0391	CbGbCtD
Dexfenfluramine—CYP2C19—Pioglitazone—type 2 diabetes mellitus	0.0144	0.0372	CbGbCtD
Dexfenfluramine—CYP2C19—Chlorpropamide—type 2 diabetes mellitus	0.0144	0.0372	CbGbCtD
Dexfenfluramine—CYP2C9—Gliclazide—type 2 diabetes mellitus	0.0141	0.0364	CbGbCtD
Dexfenfluramine—CYP2C19—Rosiglitazone—type 2 diabetes mellitus	0.0133	0.0343	CbGbCtD
Dexfenfluramine—CYP2C19—Tolbutamide—type 2 diabetes mellitus	0.0128	0.0332	CbGbCtD
Dexfenfluramine—CYP1A2—Rosiglitazone—type 2 diabetes mellitus	0.0123	0.0317	CbGbCtD
Dexfenfluramine—CYP2C9—Pioglitazone—type 2 diabetes mellitus	0.012	0.0309	CbGbCtD
Dexfenfluramine—CYP2C9—Chlorpropamide—type 2 diabetes mellitus	0.012	0.0309	CbGbCtD
Dexfenfluramine—CYP2C9—Rosiglitazone—type 2 diabetes mellitus	0.011	0.0285	CbGbCtD
Dexfenfluramine—CYP2D6—Pioglitazone—type 2 diabetes mellitus	0.0109	0.0283	CbGbCtD
Dexfenfluramine—CYP2C9—Tolbutamide—type 2 diabetes mellitus	0.0107	0.0276	CbGbCtD
Dexfenfluramine—CYP2D6—Rosiglitazone—type 2 diabetes mellitus	0.0101	0.0261	CbGbCtD
Dexfenfluramine—CYP2C9—Valsartan—type 2 diabetes mellitus	0.00975	0.0252	CbGbCtD
Dexfenfluramine—CYP1A2—Irbesartan—type 2 diabetes mellitus	0.00965	0.0249	CbGbCtD
Dexfenfluramine—CYP1A2—Bromocriptine—type 2 diabetes mellitus	0.00912	0.0236	CbGbCtD
Dexfenfluramine—CYP2C9—Nateglinide—type 2 diabetes mellitus	0.00907	0.0234	CbGbCtD
Dexfenfluramine—CYP2C9—Irbesartan—type 2 diabetes mellitus	0.00869	0.0225	CbGbCtD
Dexfenfluramine—CYP2D6—Nateglinide—type 2 diabetes mellitus	0.00829	0.0214	CbGbCtD
Dexfenfluramine—CYP2D6—Irbesartan—type 2 diabetes mellitus	0.00795	0.0205	CbGbCtD
Dexfenfluramine—CYP2C19—Glyburide—type 2 diabetes mellitus	0.00737	0.019	CbGbCtD
Dexfenfluramine—CYP2C19—Losartan—type 2 diabetes mellitus	0.00674	0.0174	CbGbCtD
Dexfenfluramine—CYP1A2—Losartan—type 2 diabetes mellitus	0.00622	0.0161	CbGbCtD
Dexfenfluramine—CYP2C9—Glyburide—type 2 diabetes mellitus	0.00613	0.0158	CbGbCtD
Dexfenfluramine—CYP2C9—Losartan—type 2 diabetes mellitus	0.0056	0.0145	CbGbCtD
Dexfenfluramine—Cinacalcet—CYP1A2—type 2 diabetes mellitus	0.000423	0.442	CrCbGaD
Dexfenfluramine—Cinacalcet—CYP3A4—type 2 diabetes mellitus	0.00028	0.293	CrCbGaD
Dexfenfluramine—Methamphetamine—ADRA2A—type 2 diabetes mellitus	0.000254	0.265	CrCbGaD
Dexfenfluramine—CYP2C9—Metabolism—CETP—type 2 diabetes mellitus	4.51e-06	8.48e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GLP1R—type 2 diabetes mellitus	4.48e-06	8.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HMGCR—type 2 diabetes mellitus	4.47e-06	8.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GNB3—type 2 diabetes mellitus	4.45e-06	8.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.45e-06	8.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—HMOX1—type 2 diabetes mellitus	4.43e-06	8.34e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.41e-06	8.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AGT—type 2 diabetes mellitus	4.39e-06	8.26e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	4.39e-06	8.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ADRA2A—type 2 diabetes mellitus	4.38e-06	8.23e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CAT—type 2 diabetes mellitus	4.37e-06	8.23e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.33e-06	8.15e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—CALM1—type 2 diabetes mellitus	4.32e-06	8.12e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCR5—type 2 diabetes mellitus	4.31e-06	8.1e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—APOE—type 2 diabetes mellitus	4.3e-06	8.09e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—APOA1—type 2 diabetes mellitus	4.25e-06	8e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APOB—type 2 diabetes mellitus	4.25e-06	7.99e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PSMD6—type 2 diabetes mellitus	4.23e-06	7.95e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SNAP25—type 2 diabetes mellitus	4.23e-06	7.95e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SREBF1—type 2 diabetes mellitus	4.23e-06	7.95e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—C3—type 2 diabetes mellitus	4.21e-06	7.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP2E1—type 2 diabetes mellitus	4.21e-06	7.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.21e-06	7.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PSMD6—type 2 diabetes mellitus	4.19e-06	7.89e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SREBF1—type 2 diabetes mellitus	4.19e-06	7.89e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SNAP25—type 2 diabetes mellitus	4.19e-06	7.89e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SLC2A2—type 2 diabetes mellitus	4.18e-06	7.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP1A2—type 2 diabetes mellitus	4.16e-06	7.82e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SLC2A1—type 2 diabetes mellitus	4.16e-06	7.82e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CTGF—type 2 diabetes mellitus	4.15e-06	7.81e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—INS—type 2 diabetes mellitus	4.15e-06	7.8e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GSTM1—type 2 diabetes mellitus	4.13e-06	7.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CTGF—type 2 diabetes mellitus	4.12e-06	7.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HMGCR—type 2 diabetes mellitus	4.11e-06	7.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CPT1A—type 2 diabetes mellitus	4.1e-06	7.71e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTR—type 2 diabetes mellitus	4.1e-06	7.71e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CCL2—type 2 diabetes mellitus	4.08e-06	7.68e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HMGCR—type 2 diabetes mellitus	4.08e-06	7.67e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CYP3A4—type 2 diabetes mellitus	4.06e-06	7.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—LPL—type 2 diabetes mellitus	4.06e-06	7.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	4.03e-06	7.59e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ADRA2A—type 2 diabetes mellitus	4.03e-06	7.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	4.02e-06	7.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NAMPT—type 2 diabetes mellitus	4.02e-06	7.56e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.01e-06	7.55e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IGF1—type 2 diabetes mellitus	4.01e-06	7.55e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT2—type 2 diabetes mellitus	4.01e-06	7.54e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IRS2—type 2 diabetes mellitus	4e-06	7.53e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AGT—type 2 diabetes mellitus	4e-06	7.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4e-06	7.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—LIPC—type 2 diabetes mellitus	3.99e-06	7.51e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HBA1—type 2 diabetes mellitus	3.99e-06	7.51e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GCK—type 2 diabetes mellitus	3.99e-06	7.51e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.99e-06	7.51e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ADRA2A—type 2 diabetes mellitus	3.99e-06	7.51e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—SLC2A4—type 2 diabetes mellitus	3.99e-06	7.5e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GCG—type 2 diabetes mellitus	3.99e-06	7.5e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP11A1—type 2 diabetes mellitus	3.97e-06	7.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ADCY5—type 2 diabetes mellitus	3.97e-06	7.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—GPX1—type 2 diabetes mellitus	3.96e-06	7.44e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CALM1—type 2 diabetes mellitus	3.93e-06	7.39e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—LEP—type 2 diabetes mellitus	3.92e-06	7.37e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APOE—type 2 diabetes mellitus	3.92e-06	7.37e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SLC9A1—type 2 diabetes mellitus	3.9e-06	7.33e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—APOA1—type 2 diabetes mellitus	3.87e-06	7.28e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP2E1—type 2 diabetes mellitus	3.87e-06	7.28e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CETP—type 2 diabetes mellitus	3.85e-06	7.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CD36—type 2 diabetes mellitus	3.85e-06	7.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP2E1—type 2 diabetes mellitus	3.83e-06	7.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SLC2A1—type 2 diabetes mellitus	3.83e-06	7.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP1A2—type 2 diabetes mellitus	3.83e-06	7.19e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.81e-06	7.17e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPP2CA—type 2 diabetes mellitus	3.8e-06	7.16e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SLC2A1—type 2 diabetes mellitus	3.79e-06	7.13e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP1A2—type 2 diabetes mellitus	3.79e-06	7.13e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PPARG—type 2 diabetes mellitus	3.75e-06	7.05e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CYP3A4—type 2 diabetes mellitus	3.73e-06	7.02e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CYP3A4—type 2 diabetes mellitus	3.7e-06	6.95e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PRKCB—type 2 diabetes mellitus	3.69e-06	6.95e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.68e-06	6.92e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—INS—type 2 diabetes mellitus	3.67e-06	6.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GCG—type 2 diabetes mellitus	3.67e-06	6.9e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—SLC2A4—type 2 diabetes mellitus	3.67e-06	6.9e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—MTHFR—type 2 diabetes mellitus	3.65e-06	6.87e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.64e-06	6.84e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.64e-06	6.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GCG—type 2 diabetes mellitus	3.64e-06	6.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—SLC2A4—type 2 diabetes mellitus	3.64e-06	6.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	3.59e-06	6.76e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PSMD6—type 2 diabetes mellitus	3.58e-06	6.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SREBF1—type 2 diabetes mellitus	3.58e-06	6.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SNAP25—type 2 diabetes mellitus	3.58e-06	6.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARA—type 2 diabetes mellitus	3.58e-06	6.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CTGF—type 2 diabetes mellitus	3.52e-06	6.61e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IRS1—type 2 diabetes mellitus	3.5e-06	6.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HMGCR—type 2 diabetes mellitus	3.49e-06	6.56e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AGT—type 2 diabetes mellitus	3.47e-06	6.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.44e-06	6.46e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.44e-06	6.46e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GNB3—type 2 diabetes mellitus	3.44e-06	6.46e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—RELA—type 2 diabetes mellitus	3.42e-06	6.44e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—HMOX1—type 2 diabetes mellitus	3.42e-06	6.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—CALM1—type 2 diabetes mellitus	3.41e-06	6.42e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADRA2A—type 2 diabetes mellitus	3.41e-06	6.42e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APOE—type 2 diabetes mellitus	3.4e-06	6.39e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CAT—type 2 diabetes mellitus	3.38e-06	6.35e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—ALB—type 2 diabetes mellitus	3.37e-06	6.34e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—APOA1—type 2 diabetes mellitus	3.36e-06	6.32e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—INS—type 2 diabetes mellitus	3.35e-06	6.29e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.29e-06	6.19e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP2E1—type 2 diabetes mellitus	3.28e-06	6.16e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOB—type 2 diabetes mellitus	3.28e-06	6.16e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SLC2A1—type 2 diabetes mellitus	3.24e-06	6.09e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.24e-06	6.09e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.24e-06	6.08e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—NOS3—type 2 diabetes mellitus	3.22e-06	6.06e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PIK3R1—type 2 diabetes mellitus	3.22e-06	6.06e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—EGFR—type 2 diabetes mellitus	3.22e-06	6.06e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GSTM1—type 2 diabetes mellitus	3.19e-06	5.99e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GNB3—type 2 diabetes mellitus	3.16e-06	5.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.16e-06	5.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CYP3A4—type 2 diabetes mellitus	3.16e-06	5.94e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—HMOX1—type 2 diabetes mellitus	3.15e-06	5.92e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.14e-06	5.91e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.13e-06	5.89e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GNB3—type 2 diabetes mellitus	3.13e-06	5.89e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—LPL—type 2 diabetes mellitus	3.13e-06	5.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—HMOX1—type 2 diabetes mellitus	3.12e-06	5.87e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	3.12e-06	5.86e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—SLC2A4—type 2 diabetes mellitus	3.11e-06	5.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GCG—type 2 diabetes mellitus	3.11e-06	5.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CAT—type 2 diabetes mellitus	3.1e-06	5.84e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—CASP3—type 2 diabetes mellitus	3.09e-06	5.81e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CAT—type 2 diabetes mellitus	3.08e-06	5.79e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.07e-06	5.78e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—IL6—type 2 diabetes mellitus	3.07e-06	5.77e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ADCY5—type 2 diabetes mellitus	3.06e-06	5.76e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—GPX1—type 2 diabetes mellitus	3.05e-06	5.74e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOB—type 2 diabetes mellitus	3.01e-06	5.67e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOB—type 2 diabetes mellitus	2.99e-06	5.62e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CD36—type 2 diabetes mellitus	2.97e-06	5.59e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PPARG—type 2 diabetes mellitus	2.96e-06	5.57e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—PTGS2—type 2 diabetes mellitus	2.95e-06	5.54e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPP2CA—type 2 diabetes mellitus	2.94e-06	5.52e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.94e-06	5.52e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.94e-06	5.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GSTM1—type 2 diabetes mellitus	2.93e-06	5.51e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.92e-06	5.49e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GSTM1—type 2 diabetes mellitus	2.91e-06	5.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—INS—type 2 diabetes mellitus	2.9e-06	5.46e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.89e-06	5.43e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—LPL—type 2 diabetes mellitus	2.88e-06	5.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—LPL—type 2 diabetes mellitus	2.85e-06	5.37e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.83e-06	5.32e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ADCY5—type 2 diabetes mellitus	2.82e-06	5.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—MTHFR—type 2 diabetes mellitus	2.82e-06	5.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—GPX1—type 2 diabetes mellitus	2.81e-06	5.28e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ADCY5—type 2 diabetes mellitus	2.79e-06	5.25e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—GPX1—type 2 diabetes mellitus	2.78e-06	5.23e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARA—type 2 diabetes mellitus	2.76e-06	5.2e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—RELA—type 2 diabetes mellitus	2.76e-06	5.2e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CD36—type 2 diabetes mellitus	2.73e-06	5.14e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CD36—type 2 diabetes mellitus	2.71e-06	5.1e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPP2CA—type 2 diabetes mellitus	2.7e-06	5.08e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—SRC—type 2 diabetes mellitus	2.69e-06	5.06e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GNB3—type 2 diabetes mellitus	2.68e-06	5.04e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.68e-06	5.04e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPP2CA—type 2 diabetes mellitus	2.68e-06	5.03e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AGT—type 2 diabetes mellitus	2.68e-06	5.03e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—HMOX1—type 2 diabetes mellitus	2.67e-06	5.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—ALB—type 2 diabetes mellitus	2.66e-06	5.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—CALM1—type 2 diabetes mellitus	2.63e-06	4.95e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CAT—type 2 diabetes mellitus	2.63e-06	4.95e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOE—type 2 diabetes mellitus	2.62e-06	4.93e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.62e-06	4.93e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—APOA1—type 2 diabetes mellitus	2.59e-06	4.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—MTHFR—type 2 diabetes mellitus	2.59e-06	4.87e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—MTHFR—type 2 diabetes mellitus	2.57e-06	4.83e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOB—type 2 diabetes mellitus	2.55e-06	4.8e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—NOS3—type 2 diabetes mellitus	2.55e-06	4.79e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PIK3R1—type 2 diabetes mellitus	2.55e-06	4.79e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARA—type 2 diabetes mellitus	2.54e-06	4.78e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARA—type 2 diabetes mellitus	2.52e-06	4.74e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	2.52e-06	4.73e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—CASP3—type 2 diabetes mellitus	2.49e-06	4.69e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GSTM1—type 2 diabetes mellitus	2.48e-06	4.67e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—IL6—type 2 diabetes mellitus	2.48e-06	4.66e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AGT—type 2 diabetes mellitus	2.46e-06	4.63e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AGT—type 2 diabetes mellitus	2.44e-06	4.59e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—LPL—type 2 diabetes mellitus	2.44e-06	4.58e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—CALM1—type 2 diabetes mellitus	2.42e-06	4.55e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOE—type 2 diabetes mellitus	2.41e-06	4.54e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.41e-06	4.52e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—CALM1—type 2 diabetes mellitus	2.4e-06	4.51e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOE—type 2 diabetes mellitus	2.39e-06	4.5e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ADCY5—type 2 diabetes mellitus	2.39e-06	4.49e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—APOA1—type 2 diabetes mellitus	2.38e-06	4.48e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—GPX1—type 2 diabetes mellitus	2.38e-06	4.47e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—APOA1—type 2 diabetes mellitus	2.36e-06	4.45e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.36e-06	4.44e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.35e-06	4.43e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.33e-06	4.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—PTGS2—type 2 diabetes mellitus	2.33e-06	4.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CD36—type 2 diabetes mellitus	2.32e-06	4.36e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPP2CA—type 2 diabetes mellitus	2.29e-06	4.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PPARG—type 2 diabetes mellitus	2.28e-06	4.3e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling by GPCR—AKT1—type 2 diabetes mellitus	2.28e-06	4.3e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—INS—type 2 diabetes mellitus	2.24e-06	4.21e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—MTHFR—type 2 diabetes mellitus	2.19e-06	4.13e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—SRC—type 2 diabetes mellitus	2.17e-06	4.08e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARA—type 2 diabetes mellitus	2.15e-06	4.05e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.11e-06	3.98e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PPARG—type 2 diabetes mellitus	2.1e-06	3.95e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AGT—type 2 diabetes mellitus	2.09e-06	3.92e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PPARG—type 2 diabetes mellitus	2.08e-06	3.92e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—INS—type 2 diabetes mellitus	2.06e-06	3.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—ALB—type 2 diabetes mellitus	2.05e-06	3.86e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—CALM1—type 2 diabetes mellitus	2.05e-06	3.86e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOE—type 2 diabetes mellitus	2.04e-06	3.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—INS—type 2 diabetes mellitus	2.04e-06	3.84e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—APOA1—type 2 diabetes mellitus	2.02e-06	3.8e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PIK3R1—type 2 diabetes mellitus	1.96e-06	3.7e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—NOS3—type 2 diabetes mellitus	1.96e-06	3.7e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.94e-06	3.65e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.9e-06	3.58e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—ALB—type 2 diabetes mellitus	1.89e-06	3.55e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—ALB—type 2 diabetes mellitus	1.87e-06	3.52e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.81e-06	3.41e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PIK3R1—type 2 diabetes mellitus	1.81e-06	3.4e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—NOS3—type 2 diabetes mellitus	1.81e-06	3.4e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—PTGS2—type 2 diabetes mellitus	1.8e-06	3.38e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PIK3R1—type 2 diabetes mellitus	1.79e-06	3.37e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—NOS3—type 2 diabetes mellitus	1.79e-06	3.37e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PPARG—type 2 diabetes mellitus	1.78e-06	3.35e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—INS—type 2 diabetes mellitus	1.75e-06	3.28e-05	CbGpPWpGaD
Dexfenfluramine—HTR2B—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.67e-06	3.15e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—PTGS2—type 2 diabetes mellitus	1.65e-06	3.11e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—PTGS2—type 2 diabetes mellitus	1.64e-06	3.08e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—ALB—type 2 diabetes mellitus	1.6e-06	3.01e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PIK3R1—type 2 diabetes mellitus	1.53e-06	2.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—NOS3—type 2 diabetes mellitus	1.53e-06	2.88e-05	CbGpPWpGaD
Dexfenfluramine—CYP2A6—Metabolism—AKT1—type 2 diabetes mellitus	1.48e-06	2.79e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—IL6—type 2 diabetes mellitus	1.46e-06	2.75e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—PTGS2—type 2 diabetes mellitus	1.4e-06	2.63e-05	CbGpPWpGaD
Dexfenfluramine—HTR2C—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.35e-06	2.54e-05	CbGpPWpGaD
Dexfenfluramine—CYP2E1—Metabolism—AKT1—type 2 diabetes mellitus	1.17e-06	2.2e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C19—Metabolism—AKT1—type 2 diabetes mellitus	9.03e-07	1.7e-05	CbGpPWpGaD
Dexfenfluramine—CYP2D6—Metabolism—AKT1—type 2 diabetes mellitus	8.31e-07	1.56e-05	CbGpPWpGaD
Dexfenfluramine—CYP2C9—Metabolism—AKT1—type 2 diabetes mellitus	8.23e-07	1.55e-05	CbGpPWpGaD
Dexfenfluramine—CYP1A2—Metabolism—AKT1—type 2 diabetes mellitus	7.04e-07	1.32e-05	CbGpPWpGaD
